PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 63 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,000 | -28.6% | 7,100 | -33.0% | 0.00% | – |
| Q1 2017 | $7,000 | -12.5% | 10,600 | -58.6% | 0.00% | – |
| Q4 2016 | $8,000 | -27.3% | 25,600 | -1.9% | 0.00% | – |
| Q3 2016 | $11,000 | +83.3% | 26,100 | +59.2% | 0.00% | – |
| Q2 2016 | $6,000 | 0.0% | 16,397 | +13.6% | 0.00% | – |
| Q1 2016 | $6,000 | -93.3% | 14,439 | -81.3% | 0.00% | -100.0% |
| Q4 2015 | $90,000 | +11.1% | 77,142 | -3.2% | 0.00% | 0.0% |
| Q3 2015 | $81,000 | -32.5% | 79,692 | -13.1% | 0.00% | 0.0% |
| Q2 2015 | $120,000 | -0.8% | 91,692 | +2.2% | 0.00% | 0.0% |
| Q1 2015 | $121,000 | -3.2% | 89,692 | +0.0% | 0.00% | -33.3% |
| Q4 2014 | $125,000 | -6.7% | 89,650 | -9.0% | 0.00% | -25.0% |
| Q3 2014 | $134,000 | -28.7% | 98,550 | -1.2% | 0.00% | -20.0% |
| Q2 2014 | $188,000 | +8.0% | 99,750 | +8.7% | 0.01% | 0.0% |
| Q1 2014 | $174,000 | +47.5% | 91,750 | +7.9% | 0.01% | +25.0% |
| Q4 2013 | $118,000 | +436.4% | 85,000 | +431.2% | 0.00% | +300.0% |
| Q3 2013 | $22,000 | +2100.0% | 16,000 | +1500.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|